Healthcare Startups Building in NYC

New York City raised a substantial sum in venture capital in 2024, making it the second-largest startup hub in the country. Healthcare took a sizable slice of that pie, and early 2026 numbers are already a notable sum. This is what happens when you stack world-class hospitals, insurance headquarters, and a deep bench of investors on top of each other in a 20-mile radius. It's what happens when you stack world-class hospitals, insurance headquarters, and a deep bench of investors on top of each other in a 20-mile radius.

Digital health alone pulled in a substantial amount in the first half of 2025, up 10% year over year, Crain's reports. By the end of 2025, NYC's digital health haul had grown to a total larger than Boston's. Life sciences and biotech made up 27% of NYC venture funding in H1 2025, making healthcare a structural pillar of the city rather than a side bet. Seedtable counts 104 funded health tech startups in New York, with the top 60 having raised a combined sum in the billions, mostly at Seed or Series A. Translation: this scene is still young. Nobody's locked in the incumbent position yet, which is either terrifying or thrilling depending on how you like your odds.

Zooming out, the picture gets bigger still. Global health startup funding reached a substantial total in 2025, and H1 2026 alone brought in a large share of that, putting the year on pace for a double-digit percentage jump. NYC is riding a wave that's already rising on its own. It's riding a wave that's already rising on its own.

The sectors where NYC health founders are building

Break down NYC's 2026 health funding by sector and four categories eat almost the whole plate: digital therapeutics at 38%, care delivery at 27%, medical AI at 20%, and insurance tech at 15%.

Digital therapeutics and care delivery lead the pack for a simple reason: both need patients, hospitals, and payers close by, and NYC has all three stacked on top of each other. You can't build a remote patient monitoring company in a vacuum. You need clinics willing to test it, patients willing to use it, and insurers willing to pay for it, and NYC hands founders all three without a plane ticket.

Medical AI's 20% share tracks with what's happening nationally, but NYC's version has its own flavor. Founders here get access to clinical data through hospital partnerships, plus a finance industry that's been doing machine learning since long before "AI" became a pitch deck buzzword. That's a lot of former quant talent looking for a new problem to solve.

Insurance tech, at 15%, is about as NYC as a bagel with a schmear. The city houses major insurer headquarters and the people who actually make payer decisions, so founders building in this space get a shot at their first enterprise customer without cold-calling across three time zones. The full range of what's getting built (telemedicine, diagnostic AI, mental health platforms, wearables, healthcare IT, biotech, insurance software) gives the sector a mix that doesn't lean on one trend to carry the whole city. If digital therapeutics cools off, care delivery or insurance tech picks up the slack. That kind of diversification is basically an insurance policy against an insurance policy.

The city's hospital systems as a founder's most valuable infrastructure

Name the anchors: NYU Langone, Mount Sinai, NewYork-Presbyterian, Memorial Sloan Kettering, Northwell Health. All within 20 miles of each other. All actively working with startups, not just tolerating them.

These hospitals aren't sitting around waiting to be sold software. Mount Sinai, Northwell, NYU Langone, and NewYork-Presbyterian are raising venture funding, partnering directly with tech companies, and launching their own startups, Crain's New York Business reported. That flips the usual founder-to-customer relationship into something closer to a founder-to-collaborator relationship.

Investors have picked up on this and built it into their expectations. NYC healthcare funds put about 40% of their capital into local deals and 60% elsewhere, but even founders pitching from outside the city are expected to show up with a clinical pilot already running at NYU Langone, Mount Sinai, or Columbia. Not a nice bonus. A prerequisite. One example: Stepful teamed up with Mount Sinai Health System in 2026 to build a training program for patient care associates, aimed at strengthening the clinical workforce across the metro area. A hospital pilot takes weeks to spin up when the hospital is a subway ride away, and months when it isn't.

The city has also put public money behind this. The LifeSci NYC initiative has poured a substantial amount into healthcare infrastructure since 2017, building out lab space and accelerator programs specifically so health founders have somewhere to land. And the proximity cuts both ways: it speeds up pilots, and it shapes who ends up founding these companies. Samir Housri and his sister Dr. Nadine Housri built Mednet while navigating their father's cancer treatment, and that company now helps over 40,000 patients nationwide. physicians handle complex case navigation. Craniometrix, tackling dementia care and having raised a meaningful amount of funding, grew out of a similarly direct brush with the clinical experience it now tries to fix. Geography doesn't just help you find customers. Sometimes it's the reason the company exists.

What NYC's payer and pharma concentration means for founders needing enterprise customers

NYC is home to the offices and decision-makers behind major health insurers, and that 15% share of health funding going to insurance tech isn't a coincidence, it's proximity turned into product. Oscar Health is the clearest proof point: built in NYC, IPO'd in March 2021 raising a substantial sum, on a bet that sitting close to the insurance establishment let its founders spot and exploit the industry's inefficiencies from the inside rather than guessing at them from afar.

Some of the newer companies are chasing the same logic at smaller scale. Fortuna, an active NYC YC company, helps consumers navigate a Medicaid system worth hundreds of billions of dollars, a market so large that its sheer size shapes what gets built around it. Avelis Health, out of one YC batch, built AI agents that audit medical claims in real time for self-insured employers and health plans, going after the tens of billions those employers waste annually on claims that never should have been paid.

None of this requires living in NYC to understand payer economics on paper. But sitting near the insurers, near the hospital systems negotiating contracts with those insurers, and near investors who've already backed payer-side companies shortens the learning curve considerably. And that sophistication cuts both ways. NYC investors know CMS reimbursement codes, value-based care contracts, and Medicare Advantage inside and out, so a founder walking in with "we'll figure out reimbursement later" gets shown the door fast. Harsh, maybe. But it's also proof the local ecosystem has seen enough of these pitches to know which ones actually work.

The investor landscape: who is writing healthcare checks in NYC

The capital stack runs deep, start to finish. At pre-seed and seed: Rock Health Capital, Healthy Ventures, 7wireVentures, Virtue, Scrub Capital, SpringRock Ventures, Digital Health Venture Partners. At growth stage: Oak HC/FT, Bessemer, Insight Partners, Flare Capital, Town Hall Ventures.

Then there's the generalist crowd that also writes health checks. General Catalyst backs digital health software at seed and Series A, comfortable with B2B2C models and long sales cycles, but it steers clear of hardware and FDA risk. Thrive Capital leans toward consumer health with strong digital models and a real path to profitability, and it skips clinical bets. FirstMark Capital focuses on health software built for clinicians and health systems. And the big firms have their own dedicated arms: a16z Bio + Health launched a sizable Biotech Ecosystem Venture Fund alongside Eli Lilly in January 2025.

Galen Growth's HT50 2025 ranking put Insight Partners at the top for early-stage digital health investing, scoring 90.8%, with Khosla Ventures, General Catalyst, and a16z Bio + Health rounding out the top four. Healthcare VC splits into distinct lanes, digital health (a substantial share of the total in 2025), biotech, medtech, and HealthAI, which is the newest and, right now, the busiest category.

The honest version of fundraising here isn't pretty. Most funds see well over a thousand healthtech decks a year and fund a small handful. Late-stage money wants outcomes data, not a promising story. And just because a firm backed one diagnostic startup doesn't mean the whole partnership writes clinical checks, so pitch the actual partner, not the firm's website. Warm intros matter more in health tech than in a typical SaaS pitch. Cold outreach without homework just means being one of a thousand decks that partner ignores that week.

The upside is the network compounds. Early backing from a seed investor like Lerer Hippeau can open doors to growth capital from Insight Partners or Thrive Capital down the line. None of this guarantees an outcome. But it's a map, and the terrain is navigable if a founder knows how to read it.

Where the current wave of NYC health founders is building

YC's September 2026 batch lists 61 healthcare startups and 22 healthcare IT startups headquartered in New York, a real signal of where early-stage energy is clustering right now.

One clear pattern: a wave of AI-native front-office tools all going after the same administrative mess from different angles. Elite, out of another YC batch, builds AI voice agents that handle scheduling, triage, referrals, refills, eligibility, intake, and billing across 18 specialties, writing back into 19 or more EHRs including Epic and athenahealth, with no rip-and-replace required. Prosper, a nine-person team from an earlier YC batch, runs AI phone agents integrated with over 80 EHRs, reporting a 50% cost reduction and tripled productivity for its clients while handling thousands of calls daily. Clarion raised a seven-figure sum from Accel, YC, and a Sequoia scout, building an AI communication layer for clinics that miss 30 to 40% of inbound calls due to staffing shortages. Trapeze, from YC's spring 2025 batch, builds voice agent clones of call center reps and onboarded more than 140 doctors in three months, serving over a million patients.

Navigation and coordination is its own cluster. Locata, from another YC batch, tackles referral management in primary care, where only about half of the 100 million specialist referrals issued annually nationwide actually get completed. actually get completed; within two weeks of building its product, Locata signed a major regional health center and saved over 100 hours of staff work in month one. Craniometrix, which has raised a substantial amount total including the majority of it in a Series A, gives families of dementia patients non-clinical coaching that avoids 30% of hospitalizations, and hit a meaningful annual recurring revenue figure after launching its care navigation service in July 2025. Fortuna handles Medicaid navigation end-to-end, eligibility through renewal, sitting as middleware on top of that same massive system.

There's also a set of companies building the plumbing that healthcare operations run on, giving operators the underlying infrastructure their systems depend on. Floracene, from a more recent YC batch, was built by two Palantir alumni and lets any healthcare operator deploy internal tools in one click, connected to production data with PHI-safe permissioning. Harbera, from an earlier YC batch, uses AI to continuously monitor and re-credential doctors, catching problems before they turn into denied claims. Arctic Health, from YC's spring 2026 batch, handles credentialing and contracting end-to-end, from payer contracts to provider enrollment. YouShift, a ten-person team from that same earlier YC batch, automates hospital shift scheduling and is replacing legacy software that's been sitting untouched for a decade.

And then there's the clinical, science-heavy end of the spectrum. CellType, from a later YC batch, runs an agentic drug discovery pipeline built on biological foundation models developed with Google DeepMind, and has already found and validated a new cancer treatment signal. Allia Health, from that same later YC batch, runs a full-stack AI-native mental health practice with more than 600 providers, including over 350 therapists, across 70 sites in 32 states plus nationwide telehealth. Nourish runs a telehealth nutrition platform with over 10,000 dietitians, working directly with major insurers so many patients pay nothing out of pocket. Avelis Health, in under five months, helped 60 patients erase or reduce more than $300,000 in medical bills before shifting its focus upstream to payment integrity work.

The exits give a sense of where this all leads. Flatiron Health, founded in 2012, sold to Roche in 2018 for a sum in the billions. Oscar Health went public in March 2021, raising a substantial sum. Tempus acquired Paige in 2025 to expand into digital pathology, pulling in Paige's roughly 7 million digitized pathology slides to build out its oncology foundation model. None of this is a full directory of what's happening. It's a sample big enough to show the range, and specific enough to show the depth.

Where NYC health startups physically set up

Most early-stage health startups in the city work out of coworking spaces clustered in a few neighborhoods known for startup activity, close enough to walk to a hospital meeting and still make it back for a 2pm investor call. That geography isn't random. It puts founders within a short cab ride of the hospital systems running their pilots, the insurers reviewing their contracts, and the investors deciding on the next round.

The talent pool feeding these companies pulls from a few different rivers at once: clinicians who've worked inside NYU Langone or Mount Sinai and know exactly where the operational pain points sit, machine learning engineers who cut their teeth in the city's finance sector before pivoting to health data, and product people who've already been through a healthcare IT company's ups and downs. That mix (clinical fluency, technical depth, operating experience) appears together like this in every city only rarely. It shows up here because all three worlds already share the same zip codes.